PubRank

G Koren

Author PubWeight™ 518.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997 5.35
2 Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994 5.32
3 Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985 4.87
4 Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. N Engl J Med 1997 4.37
5 Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med 1995 3.88
6 Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998 3.67
7 Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 1998 3.58
8 Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000 3.36
9 Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet 1995 3.31
10 Voltage-sensing residues in the S4 region of a mammalian K+ channel. Nature 1991 3.01
11 Piracetam therapy does not enhance cognitive functioning in children with down syndrome. Arch Pediatr Adolesc Med 2001 2.72
12 Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 1998 2.61
13 Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. JAMA 1999 2.47
14 Maternal ginseng use associated with neonatal androgenization. JAMA 1990 2.43
15 Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 1987 2.37
16 Use of misoprostol during pregnancy and Möbius' syndrome in infants. N Engl J Med 1998 2.35
17 Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996 2.35
18 Directly measured second hand smoke exposure and asthma health outcomes. Thorax 2005 2.32
19 Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2008 2.31
20 Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997 2.21
21 Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001 2.19
22 Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA 1994 2.18
23 Combined analgesia and local anesthesia to minimize pain during circumcision. Arch Pediatr Adolesc Med 2000 2.16
24 Toxic effects of atenolol consumed during breast feeding. J Pediatr 1989 2.11
25 Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001 2.08
26 Empirical examination of the ability of children to consent to clinical research. J Med Ethics 1998 2.03
27 Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986 2.01
28 Errors by paediatric residents in calculating drug doses. Arch Dis Child 1998 1.99
29 Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001 1.99
30 Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 2000 1.97
31 Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997 1.80
32 Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000 1.78
33 The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998 1.76
34 Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 1995 1.75
35 Safety of the new quinolones in pregnancy. Obstet Gynecol 1994 1.75
36 Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod Toxicol 1998 1.73
37 Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001 1.69
38 Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress 2008 1.68
39 Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Arch Womens Ment Health 2005 1.68
40 An assessment of cortisol analysis in hair and its clinical applications. Forensic Sci Int 2010 1.66
41 Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. J Pediatr 1985 1.65
42 Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci U S A 1998 1.64
43 Determination of gestational cocaine exposure by hair analysis. JAMA 1989 1.63
44 The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005 1.62
45 Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics 2001 1.62
46 Arthropathy in thalassaemia patients receiving deferiprone. Lancet 1994 1.62
47 Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 1995 1.60
48 Therapeutic abortions due to severe morning sickness. Unacceptable combination. Can Fam Physician 1997 1.59
49 Camphorated oil: still endangering the lives of Canadian children. CMAJ 1995 1.58
50 Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 1996 1.57
51 Accidental electric shock in pregnancy: a prospective cohort study. Am J Obstet Gynecol 1997 1.55
52 Characteristics of pregnant women who engage in binge alcohol consumption. CMAJ 1997 1.53
53 Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995 1.53
54 Outpatient treatment of croup with nebulized dexamethasone. Arch Pediatr Adolesc Med 1996 1.52
55 Tibial hemimelia and tetralogy of Fallot associated with first trimester exposure to amantadine. Reprod Toxicol 1994 1.52
56 Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 1990 1.48
57 Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 1992 1.47
58 The association between maternal cigarette smoking and psychiatric diseases or criminal outcome in the offspring: a precautionary note about the assumption of causation. Reprod Toxicol 1999 1.47
59 Intranasal midazolam for febrile seizures. A step forward in treating a common and distressing condition. BMJ 2000 1.45
60 Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits. Clin Pharmacol Ther 2010 1.44
61 Hair analysis provides a historical record of cortisol levels in Cushing's syndrome. Exp Clin Endocrinol Diabetes 2009 1.44
62 Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine. Ann Pharmacother 1997 1.43
63 The safety of dextromethorphan in pregnancy : results of a controlled study. Chest 2001 1.42
64 The safety of astemizole in pregnancy. J Allergy Clin Immunol 1996 1.41
65 Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology 1991 1.40
66 Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient. Can J Anaesth 1992 1.39
67 Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. J Obstet Gynaecol 2009 1.39
68 Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. J Toxicol Clin Toxicol 1998 1.39
69 Congenital rubella syndrome. How can we do better? Can Fam Physician 1999 1.39
70 A randomized, double-blind comparison of lumbar epidural and intravenous fentanyl infusions for postthoracotomy pain relief. Analgesic, pharmacokinetic, and respiratory effects. Anesthesiology 1992 1.39
71 Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. Can Fam Physician 1999 1.38
72 The transfer of 6-mercaptopurine in the dually perfused human placenta. Reprod Toxicol 2011 1.38
73 Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol 2000 1.37
74 Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993 1.36
75 Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 1997 1.35
76 Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001 1.34
77 Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001 1.31
78 Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986 1.29
79 A revised measure of acute pain in infants. J Pain Symptom Manage 1995 1.29
80 Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001 1.28
81 Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 1998 1.27
82 A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates. Pediatrics 1998 1.27
83 Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991 1.26
84 Errors in computing drug doses. Can Med Assoc J 1983 1.26
85 Modeling supra-molecular helices: extension of the molecular surface recognition algorithm and application to the protein coat of the tobacco mosaic virus. J Mol Biol 1997 1.26
86 Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992 1.24
87 Physician compliance and relapse rates of acute lymphoblastic leukemia in children. Clin Pharmacol Ther 1988 1.24
88 Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology 1989 1.23
89 Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Clin Pharmacol Ther 2012 1.23
90 Motherisk--a new approach to antenatal counselling of drug/chemical exposure. Vet Hum Toxicol 1986 1.23
91 Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate 1997 1.22
92 Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003 1.20
93 A double-blind, randomized, placebo-controlled trial of eutectic lidocaine/prilocaine cream 5% (EMLA) for analgesia prior to cryotherapy of warts in children and adults. Pediatr Dermatol 1998 1.20
94 Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol 2001 1.19
95 Assembly of mammalian voltage-gated potassium channels: evidence for an important role of the first transmembrane segment. Neuron 1994 1.18
96 Use of lidocaine-prilocaine cream for vaccination pain in infants. J Pediatr 1994 1.17
97 Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets. Crit Care Med 1985 1.16
98 Use of the nicotine patch by pregnant women. N Engl J Med 1999 1.16
99 Drug-induced aplastic anemia: pathogenesis and clinical aspects. Am J Pediatr Hematol Oncol 1990 1.16
100 Hair analysis--a biological marker for passive smoking in pregnancy and childhood. Hum Exp Toxicol 1999 1.15
101 Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. Am J Dis Child 1983 1.15
102 Compliance assessed by the Medication Event Monitoring System. Arch Dis Child 1991 1.15
103 Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994 1.15
104 Prevalence of fetal exposure to cocaine in Toronto, 1990-1991. Clin Invest Med 1994 1.14
105 Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther 2007 1.14
106 Paediatric clinical pharmacology and the health of the world's children. Dev Pharmacol Ther 1990 1.13
107 Pregnancy outcome following maternal organic solvent exposure: a meta-analysis of epidemiologic studies. Am J Ind Med 1998 1.13
108 Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate. Reprod Toxicol 1994 1.13
109 Neurodevelopment of adopted children exposed in utero to cocaine. CMAJ 1994 1.13
110 Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. JAMA 1990 1.12
111 Characterization of a slowly inactivating outward current in adult mouse ventricular myocytes. Circ Res 1998 1.11
112 Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993 1.10
113 Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 1992 1.10
114 Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 1995 1.09
115 Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada. Clin Invest Med 1992 1.09
116 Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med 2000 1.09
117 Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000 1.07
118 Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. Am J Physiol Heart Circ Physiol 2012 1.07
119 Exposure to organic solvents. Does it adversely affect pregnancy? Can Fam Physician 1999 1.07
120 Reproductive risks of binge drinking during pregnancy. Reprod Toxicol 1997 1.07
121 Choice of breastfeeding and physicians' advice: a cohort study of women receiving propylthiouracil. Pediatrics 2000 1.07
122 Methotrexate exposure prior to and during pregnancy. Teratology 1994 1.06
123 The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy. J Clin Pharmacol 2001 1.05
124 The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996 1.04
125 Identifying the behavioural phenotype in Fetal Alcohol Spectrum Disorder: sensitivity, specificity and screening potential. Arch Womens Ment Health 2006 1.03
126 Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. Lancet 1990 1.03
127 Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol 2011 1.03
128 Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol 1998 1.03
129 Passive smoking in children. Racial differences in systemic exposure to cotinine by hair and urine analysis. Chest 1996 1.03
130 Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol 1999 1.03
131 The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta 2008 1.02
132 Clinical applications of hair testing for drugs of abuse--the Canadian experience. Forensic Sci Int 2000 1.02
133 Characterization of mice with a combined suppression of I(to) and I(K,slow). Am J Physiol Heart Circ Physiol 2001 1.01
134 The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod Toxicol 1999 1.01
135 Attitudes and practices of physicians and naturopaths toward herbal products, including use during pregnancy and lactation. Can J Clin Pharmacol 2000 1.01
136 The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther 2011 1.01
137 Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 1997 1.01
138 Morphine-induced seizures in newborn infants. Vet Hum Toxicol 1985 1.01
139 Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. Placenta 2006 1.01
140 Steady state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg 1993 1.00
141 Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia. J Pediatr 1990 1.00
142 Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997 1.00
143 Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. J Clin Pharmacol 2000 1.00
144 A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther 1985 1.00
145 Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Dev Pharmacol Ther 1992 0.99
146 Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta 2007 0.99
147 Vancomycin pharmacokinetics and dose recommendations for preterm infants. Antimicrob Agents Chemother 1987 0.99
148 Exposure to ionizing radiation during pregnancy: perception of teratogenic risk and outcome. Teratology 1991 0.99
149 Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study. Clin Invest Med 2001 0.99
150 A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 1998 0.99
151 Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). Neurotoxicol Teratol 2002 0.99
152 Hair analysis as a marker for fetal exposure to maternal smoking. N Engl J Med 1993 0.98
153 Effects of prenatal exposure to marijuana. Can Fam Physician 2001 0.98
154 Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada. Int J Gynaecol Obstet 2000 0.98
155 Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 1998 0.98
156 Pregnancy outcome following use of large doses of vitamin B6 in the first trimester. J Obstet Gynaecol 2006 0.98
157 Prenatal exposure to organic solvents and child neurobehavioral performance. Neurotoxicol Teratol 2001 0.97
158 Vancomycin pharmacokinetics in very low birth weight neonates. Pediatr Infect Dis J 1989 0.97
159 Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking. Clin Invest Med 1996 0.97
160 A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv1.1 potassium channel polypeptides and native Kv1.4 and Kv1.5 channels in the endoplasmic reticulum. J Biol Chem 1997 0.96
161 Validation of self-reported smoking by analysis of hair for nicotine and cotinine. Ther Drug Monit 1996 0.96
162 Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996 0.96
163 Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci 1994 0.96
164 Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 1999 0.96
165 Intravenous paraldehyde for seizure control in newborn infants. Neurology 1986 0.96
166 Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth. Depress Anxiety 2010 0.95
167 Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling. Oncogene 2008 0.95
168 Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991 0.95
169 Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 2001 0.95
170 Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J 1990 0.95
171 Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q-T phenotype. Am J Physiol Heart Circ Physiol 2000 0.95
172 Meta-analytic review of the clinical effectiveness of oral deferiprone (L1). Eur J Clin Pharmacol 1999 0.95
173 Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). Eur J Clin Pharmacol 1984 0.94
174 The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol 1995 0.94
175 Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992 0.94
176 Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr 1988 0.94
177 Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety. J Clin Pharmacol 1998 0.94
178 N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol 2008 0.94
179 SAP97 interacts with Kv1.5 in heterologous expression systems. Am J Physiol Heart Circ Physiol 2001 0.94
180 Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis. Ther Drug Monit 1994 0.94
181 Treatment of epilepsy in pregnancy. Drugs 1999 0.94
182 Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study. Dig Dis Sci 1996 0.94
183 Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway. Biochem J 1997 0.94
184 Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 1992 0.94
185 Evidence for pairing above the transition temperature of cuprate superconductors from the electronic dispersion in the pseudogap phase. Phys Rev Lett 2008 0.93
186 Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol 2011 0.93
187 Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta 1999 0.93
188 Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program. CMAJ 1999 0.93
189 A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm 1988 0.93
190 Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). Can J Clin Pharmacol 2000 0.93
191 The safety of fetal exposure to proton-pump inhibitors during pregnancy. Dig Dis Sci 2011 0.93
192 Binge alcohol consumption by non-alcohol-dependent women during pregnancy affects child behaviour, but not general intellectual functioning; a prospective controlled study. Arch Womens Ment Health 2004 0.93
193 Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch Dis Child Fetal Neonatal Ed 2006 0.92
194 Preconception counseling and women's compliance with folic acid supplementation. Can Fam Physician 1999 0.92
195 Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997 0.92
196 Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1). Can J Physiol Pharmacol 1993 0.92
197 The transcription of a mammalian voltage-gated potassium channel is regulated by cAMP in a cell-specific manner. J Biol Chem 1993 0.92
198 Ischemic colitis in chronic intermittent peritoneal dialysis. Nephron 1984 0.92
199 Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985 0.92
200 Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994 0.91
201 Invasive mucormycosis in a non-immunocompromised patient. J Infect 1986 0.91
202 Oral iron chelation with deferiprone. Pediatr Clin North Am 1997 0.91
203 Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. Can Fam Physician 2001 0.91
204 Pretranslational mechanisms determine the type of potassium channels expressed in the rat skeletal and cardiac muscles. J Biol Chem 1991 0.91
205 Effects of framing on teratogenic risk perception in pregnant women. Lancet 2001 0.91
206 Noninvasive methods for drug measurement in pediatrics. Pediatr Clin North Am 1997 0.91
207 Acid-suppressing drugs during pregnancy. Can Fam Physician 1997 0.91
208 Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol 2008 0.90
209 Existence and severity of nausea and vomiting in pregnancy (NVP) with different partners. J Obstet Gynaecol 2007 0.90
210 Antidepressants and breast-feeding. Am J Psychiatry 1997 0.90
211 Bendectin/diclectin for morning sickness: a Canadian follow-up of an American tragedy. Reprod Toxicol 1996 0.90
212 The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol 1998 0.90
213 Maternal noncompliance with antibiotics during breastfeeding. Ann Pharmacother 1993 0.90
214 GH3 cell-specific expression of Kv1.5 gene. Regulation by a silencer containing a dinucleotide repetitive element. J Biol Chem 1995 0.90
215 Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. Teratog Carcinog Mutagen 1993 0.90
216 Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 1991 0.90
217 Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 2000 0.89
218 The influence of hypothermia on the disposition of fentanyl--human and animal studies. Eur J Clin Pharmacol 1987 0.89
219 Clinical pharmacology and therapeutic drug monitoring in neonates and children. Pediatr Rev 1998 0.89
220 Maternal and neonatal characteristics following exposure to cocaine in Toronto. Reprod Toxicol 1994 0.89
221 Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sci 2000 0.89
222 Vitamin C-induced erythrocyte damage in premature infants. J Pediatr 1988 0.89
223 Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. Neurotoxicol Teratol 1998 0.89
224 Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations. Pediatr Infect Dis J 1993 0.89
225 Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anesth Analg 1985 0.88
226 Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. Am J Physiol 1992 0.88
227 Bioavailability of nifedipine: a comparison between two preparations. Biopharm Drug Dispos 1984 0.88
228 Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. Blood 1992 0.88
229 The transfer of pravastatin in the dually perfused human placenta. Placenta 2013 0.88
230 Use of hair analysis for confirmation of self-reported cocaine use in users with negative urine tests. J Toxicol Clin Toxicol 2001 0.87
231 Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid. Neurology 1997 0.87
232 Topical skin anesthesia for venous, subcutaneous drug reservoir and lumbar punctures in children. Pediatrics 1989 0.87
233 SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth 2005 0.87
234 Quality assessment of observational studies in psychiatry: an example  from perinatal psychiatric research. Int J Methods Psychiatr Res 2011 0.87
235 Feasibility of pre-hospital fibrinolytic therapy in acute myocardial infarction. Am J Emerg Med 1986 0.87
236 Effects of maternal occupational exposure to organic solvents on offspring visual functioning: a prospective controlled study. Teratology 2001 0.87
237 Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol 1991 0.87
238 Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants? J Dev Behav Pediatr 1999 0.86
239 Long-term restitution of 4-aminopyridine-sensitive currents in Kv1DN ventricular myocytes using adeno-associated virus-mediated delivery of Kv1.5. FEBS Lett 2003 0.86
240 Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 2001 0.86
241 Nausea and vomiting in pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol 1998 0.86
242 Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J 1998 0.86
243 High-frequency oscillation in the rescue of infants with persistent pulmonary hypertension. Crit Care Med 1988 0.86
244 Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999 0.86
245 Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. Pediatrics 1998 0.86
246 A 2013 updated systematic review & meta-analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti-inflammatory agents on the risk of bleeding after tonsillectomy. Clin Otolaryngol 2013 0.85
247 Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. Am J Physiol 1999 0.85
248 Relative efficacy of amethocaine gel and lidocaine-prilocaine cream for Port-a-Cath puncture in children. Pediatrics 1999 0.85
249 Folic acid and prevention of neural tube defects: a study of Canadian mothers of infants with spina bifida. Clin Invest Med 1996 0.85
250 Non-Hodgkin's lymphoma and pregnancy. Leuk Lymphoma 1994 0.85
251 Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer 2007 0.85
252 Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon. Am J Obstet Gynecol 1994 0.85
253 Comparing the effectiveness of TWEAK and T-ACE in determining problem drinkers in pregnancy. Alcohol Alcohol 2010 0.85
254 Evaluating the efficacy of EMLA in alleviating pain associated with lumbar puncture; comparison of open and double-blinded protocols in children. Pain 1990 0.85
255 Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol 1999 0.85
256 In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy. Eur J Cancer 2003 0.85
257 Arylamine N-acetyltransferase activity of the human placenta. J Pharmacol Exp Ther 1994 0.85
258 Lead exposure, gestational hypertension and pre-eclampsia: a systematic review of cause and effect. J Obstet Gynaecol 2012 0.85
259 Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998 0.85
260 P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. Life Sci 1993 0.84
261 The transfer of ethyl glucuronide across the dually perfused human placenta. Placenta 2013 0.84
262 Pharmacokinetics of oral and intravenous bromide in normal volunteers. J Toxicol Clin Toxicol 1986 0.84
263 A model for the prediction of digoxin-drug interactions at the renal tubular cell level. Ther Drug Monit 1998 0.84
264 Anticonvulsants and breast feeding: a critical review. Paediatr Drugs 2000 0.84
265 Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol 1992 0.84
266 Comparison of the pharmacokinetics of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in healthy volunteers, with and without co-administration of ferrous sulfate, to thalassemia patients. Int J Clin Pharmacol Ther Toxicol 1993 0.84
267 Effects of indomethacin on digoxin pharmacokinetics in preterm infants. Pediatr Pharmacol (New York) 1984 0.84
268 Audiologic profiles of children with Kawasaki disease. Am J Otol 1992 0.84
269 Pregnancy outcome after exposure to oral contraceptives during the periconceptional period. Hum Exp Toxicol 2008 0.84
270 Significance of the endogenous digoxin-like substance in infants and mothers. Clin Pharmacol Ther 1984 0.84
271 Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Placenta 2010 0.84
272 Monitoring and avoiding drug and chemical teratogenicity. CMAJ 1986 0.84
273 Homocysteine, folate and pregnancy outcomes. J Obstet Gynaecol 2012 0.84
274 Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta 2005 0.83
275 Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with thalassemia. Clin Pharmacol Ther 1991 0.83
276 The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sci 1993 0.83
277 Pharmacokinetic predisposition to nicotine from environmental tobacco smoke: a risk factor for pediatric asthma. J Asthma 1998 0.83
278 Determinants of the need for hospital care among women with nausea and vomiting of pregnancy. Clin Invest Med 2001 0.83
279 Adolescent dimenhydrinate abuse: resurgence of an old problem. J Adolesc Health 1997 0.83
280 Safety of vancomycin with or without gentamicin in neonates. Neonatal Netw 1993 0.83
281 A systematic review of the fetal safety of interferon alpha. Reprod Toxicol 2011 0.83
282 Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. Am J Trop Med Hyg 1998 0.83
283 Interactions of clobazam with conventional antiepileptics in children. J Child Neurol 1997 0.83
284 The safety of fluoxetine during pregnancy and lactation. Teratology 1996 0.83
285 Alcohol and breast feeding: calculation of time to zero level in milk. Biol Neonate 2001 0.83
286 Vancomycin-induced red man syndrome. Pediatrics 1990 0.83
287 Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma. Cancer 2001 0.83
288 Glucose metabolism is elevated and vascular resistance and maternofetal transfer is normal in perfused placental cotyledons from severely growth-restricted fetuses. Pediatr Res 2000 0.83
289 Contamination of antibiotics resulting in severe pediatric methadone poisoning. Ann Pharmacother 1999 0.83
290 Morphine pharmacokinetics in children following cardiac surgery: effects of disease and inotropic support. J Cardiothorac Vasc Anesth 1993 0.82
291 Management of paracetamol overdose: current controversies. Drug Saf 2001 0.82
292 Observation of magnetic flux generated spontaneously during a rapid quench of superconducting films. Phys Rev Lett 2003 0.82
293 Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. Reprod Toxicol 1992 0.82
294 Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 1991 0.82
295 Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can Fam Physician 1999 0.82
296 Are the new SSRIs safe for pregnant women? Can Fam Physician 1998 0.82
297 Renal handling of cisplatin: interactions with organic anions and cations in the dog. Clin Invest Med 1991 0.82
298 Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response. J Clin Pharmacol 1998 0.82
299 Purification and preliminary characterization of a cardiac Kv1.5 repressor element binding factor. Circ Res 1999 0.82
300 Exposure to sibutramine during pregnancy: a case series. Eur J Obstet Gynecol Reprod Biol 2004 0.82
301 Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 2000 0.82
302 Initiation and duration of breast-feeding in women receiving antiepileptics. Am J Obstet Gynecol 1995 0.82
303 Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosis. Med Hypotheses 1998 0.82
304 Bradycardia and hypotension following reperfusion with streptokinase (Bezold-Jarisch reflex): a sign of coronary thrombolysis and myocardial salvage. Am Heart J 1986 0.82
305 Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 1994 0.82
306 Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease. Blood 1994 0.82
307 Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med 1999 0.82
308 Principles of drug prescribing in infants and children. A practical guide. Drugs 1993 0.82
309 Lumbar epidural fentanyl infusions for post-thoracotomy patients: analgesic, respiratory, and pharmacokinetic effects. J Cardiothorac Anesth 1990 0.81
310 Pregnancy-induced changes in drug metabolism in epileptic women. J Pharmacol Exp Ther 1991 0.81
311 The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol 2013 0.81
312 Assessing pain and analgesia with a lidocaine-prilocaine emulsion in infants and toddlers during venipuncture. J Pediatr 1991 0.81
313 A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects. Anesthesiology 1994 0.81
314 Safety of first-trimester exposure to topical tretinoin: prospective cohort study. Lancet 1997 0.81
315 An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major. Ther Drug Monit 1999 0.81
316 Pharmacokinetics of intravenous clindamycin in newborn infants. Pediatr Pharmacol (New York) 1986 0.81
317 A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990 0.81
318 Interpretation of excessive levels of inhaled tobramycin. Ther Drug Monit 1989 0.81
319 Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration. Pediatr Radiol 1995 0.81
320 Salivary measurement of deferiprone concentrations and correlation with serum levels. Ther Drug Monit 1997 0.81
321 The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levels. Int J Clin Pharmacol Ther 1996 0.81
322 Therapeutic drug monitoring of retinoids. Ther Drug Monit 1992 0.81
323 Home-based palliative care for children--Part 2: The benefits of an established program. J Palliat Care 1990 0.81
324 Vancomycin dosing in preterm infants: prospective verification of new recommendations. J Pediatr 1987 0.81
325 The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal. Gastroenterology 1991 0.81
326 Motherisk alert: Folic acid fortification of flour--three years later. Can J Clin Pharmacol 2001 0.81
327 Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience. J Psychiatry Neurosci 1997 0.81
328 Digoxin toxicity associated with amiodarone therapy in children. J Pediatr 1984 0.81
329 The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin study. Can J Physiol Pharmacol 2001 0.81
330 Cocaine inhibits hCG secretion by the human term placental cotyledon perfused in vitro. Life Sci 1996 0.81
331 Human placental transfer and metabolism of p-aminobenzoic acid. J Pharmacol Exp Ther 1994 0.80
332 Impairment of pyruvate dehydrogenase activity by acetaldehyde. Alcohol 2001 0.80
333 Immune function in patients with beta thalassaemia receiving the orally active iron-chelating agent deferiprone. Br J Haematol 1997 0.80
334 Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition. Ther Drug Monit 2001 0.80
335 Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function. J Biol Chem 1999 0.80
336 Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study. J Burn Care Rehabil 2001 0.80
337 Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients. Semin Hematol 1990 0.80
338 Penile absorption of EMLA cream in piglets: implications for use of EMLA in neonatal circumcision. Biol Neonate 1995 0.80
339 Maternal obesity: effects on pregnancy and the role of pre-conception counselling. J Obstet Gynaecol 2010 0.80
340 Digoxin-amiodarone interaction: in vivo and in vitro studies in rats. Can J Physiol Pharmacol 1983 0.80
341 Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. J Pediatr 1984 0.80
342 Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. Am J Kidney Dis 1996 0.80
343 Postmortem redistribution of digoxin in rats. J Forensic Sci 1985 0.80
344 Maternal and obstetric effects of prenatal drug exposure. Clin Perinatol 1999 0.80
345 Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children. Ther Drug Monit 1998 0.80
346 Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis. Ther Drug Monit 1987 0.80
347 Urine fingerprinting: detection of sample tampering in an opiate dependency program. Ther Drug Monit 1999 0.80
348 Pharmacokinetic interaction between nifedipine and propranolol. Fundam Clin Pharmacol 1988 0.80
349 Testing women for HIV. Can Fam Physician 1997 0.80
350 Outcomes of infants exposed to multiple antidepressants during pregnancy: results of a cohort study. J Popul Ther Clin Pharmacol 2011 0.80
351 Misdiagnosis of a mexiletine overdose because of a nonspecific result of urinary toxicologic screening. N Engl J Med 2000 0.80
352 Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. J Psychosom Obstet Gynaecol 2003 0.80
353 Organization and efficacy of a therapeutic drug monitoring consultation service in a pediatric hospital. Ther Drug Monit 1985 0.80
354 Deferoxamine (desferrioxamine). New toxicities for an old drug. Drug Saf 1991 0.80
355 The effect of diazepam in the recovery of rabbits from acute acetaminophen intoxication. Ther Drug Monit 1999 0.79
356 Complications resulting from use of arterial catheters: retrograde flow and rapid elevation in blood pressure. Pediatrics 1985 0.79
357 Periconception folic acid supplementation. Knowledge and practice of Canadian family physicians. Can Fam Physician 1997 0.79
358 An unusual skin exposure to copper; clinical and pharmacokinetic evaluation. J Toxicol Clin Toxicol 1988 0.79
359 Preconception counseling: rational, practice and challenges. Minerva Ginecol 2011 0.79
360 Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. Int J Clin Pharmacol Ther 1998 0.79
361 Transfer of morphine across the human placenta and its interaction with naloxone. Life Sci 1999 0.79
362 A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther Drug Monit 1994 0.79
363 Recent increases in numbers and risk of fatalities in young children ingesting iron preparations. Vet Hum Toxicol 1994 0.79
364 Pregnancy outcome of women exposed to pinaverium due to a dispensing error. Ann Pharmacother 1999 0.79
365 Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children. J Pediatr 1990 0.79
366 The efficacy of oral deferiprone in acute iron poisoning. Am J Emerg Med 2000 0.79
367 Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes. Can Fam Physician 2001 0.79
368 Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. J Clin Oncol 1995 0.79
369 Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. Ther Drug Monit 1997 0.79
370 Fetal response to maternally administered morphine. Am J Obstet Gynecol 2000 0.79
371 Cisapride use during human pregnancy: a prospective, controlled multicenter study. Dig Dis Sci 1997 0.79
372 Acetylcholinesterase and butyrylcholinesterase activity in the human term placenta: implications for fetal cocaine exposure. J Lab Clin Med 1994 0.78
373 Kinetics of CSF phenytoin in children. Can J Neurol Sci 1983 0.78
374 A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol 1994 0.78
375 Pediatric clinical use of the ketoconazole/cyclosporin interaction. Pediatr Nephrol 1994 0.78
376 Prenatal multivitamins containing folic acid do not decrease prevalence of depression among pregnant women. J Obstet Gynaecol 2008 0.78
377 Valproic acid use in psychiatry: issues in treating women of reproductive age. J Psychiatry Neurosci 1998 0.78
378 Zopiclone use during pregnancy. Can Fam Physician 2000 0.78
379 Therapeutic approach to hypertension during pregnancy. Can Fam Physician 1998 0.78
380 Drug transfer across the placenta. Considerations in treatment and research. Clin Perinatol 1994 0.78
381 Maternal cocaine use without evidence of fetal exposure. J Pediatr 1994 0.78
382 Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis. Ther Drug Monit 1994 0.78
383 Safety of lidocaine-prilocaine cream in the treatment of preterm neonates. J Pediatr 1995 0.78
384 Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf 1999 0.78
385 Tenfold errors in drug dosage. CMAJ 1988 0.78
386 Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test. Dig Dis Sci 1985 0.78
387 Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions. J Obstet Gynaecol 2009 0.78
388 The Toronto experience in diagnosing alcohol-related neurodevelopmental disorder: a unique profile of deficits and assets. Can J Clin Pharmacol 2002 0.78
389 The transport of digoxin across the perfused human placental lobule. J Pharmacol Exp Ther 1991 0.78
390 Cerebrospinal fluid pharmacokinetics of tobramycin, ceftazidime, phenobarbitone and phenytoin in a child. Clin Pharmacokinet 1985 0.78
391 Influence of food on the bioavailability of oral methotrexate in children. J Rheumatol 1995 0.78
392 The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol Teratol 1997 0.78
393 Effect of lidocaine-prilocaine cream on pain from subcutaneous injection. Clin Pharm 1992 0.78
394 Glutathione stability in whole blood: effects of various deproteinizing acids. Ther Drug Monit 2001 0.78
395 Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use. Forensic Sci Int 2009 0.78
396 Epileptics refractory to anticonvulsants. Neurology 1984 0.78
397 Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care. Br J Gen Pract 1999 0.78
398 Reduction of platelet counts induced by mechanical ventilation in newborn infants. J Pediatr 1987 0.78
399 Solid-phase microextraction for the detection of codeine, morphine and 6-monoacetylmorphine in human hair by gas chromatography-mass spectrometry. Forensic Sci Int 2010 0.78
400 Lack of cisplatin-ranitidine kinetic interactions: in vivo study in children, and in vitro study using dog renal brush border membrane vesicles. Life Sci 1998 0.78
401 Fetal distribution of cocaine: case analysis. Pediatr Pathol 1992 0.78
402 Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci 2001 0.78
403 The effects of cocaine and nicotine on amino acid transport across the human placental cotyledon perfused in vitro. J Pharmacol Exp Ther 2000 0.78
404 Accumulation of cocaine in maternal and fetal hair; the dose response curve. Life Sci 1992 0.77
405 Pain perception and effectiveness of the eutectic mixture of local anesthetics in children undergoing venipuncture. Pediatr Res 1992 0.77
406 A randomized prospective crossover trial of amlodipine in pediatric hypertension. Pediatr Nephrol 2000 0.77
407 Maturation of renal tubular transport of gentamicin. Dev Pharmacol Ther 1984 0.77
408 Iphosphamide-induced nephrotoxicity in children. Pediatr Nephrol 1992 0.77
409 Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia. Crit Care Med 1990 0.77
410 Occupational exposure to inhaled anesthetic. Is it a concern for pregnant women? Can Fam Physician 2000 0.77
411 Fetal and neonatal outcomes in women taking domperidone during pregnancy. J Obstet Gynaecol 2013 0.77
412 Correlation of morphine sulfate in blood plasma and saliva in pediatric patients. Ther Drug Monit 1997 0.77
413 Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night. Lancet 1987 0.77
414 Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected]. Paediatr Anaesth 2008 0.77
415 Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. J Pediatr 1987 0.77
416 Pharmacological treatment for pregnant women who smoke cigarettes. Tob Induc Dis 2003 0.77
417 Universal HIV testing in pregnancy. Can Fam Physician 2000 0.77
418 Acute iron intoxication: significant differences between sexes. Vet Hum Toxicol 1997 0.77
419 How long should someone wait after CMV infection to start pregnancy? Can Fam Physician 1998 0.77
420 Pemoline-associated fulminant liver failure: testing the evidence for causation. Clin Pharmacol Ther 1995 0.77
421 Possible indomethacin-aminoglycoside interaction in preterm infants. J Pediatr 1985 0.77
422 Prospective, controlled, multicentre study of loperamide in pregnancy. Can J Gastroenterol 2000 0.77
423 Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity. Clin Pharmacol Ther 1990 0.77
424 Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence. Can Fam Physician 2001 0.77
425 Decreased theophylline clearance causing toxicity in children during viral epidemics. J Asthma 1985 0.77
426 Pharmacokinetic analysis of cloxacillin loss in children undergoing major surgery with massive bleeding. Antimicrob Agents Chemother 1990 0.77
427 Hypoxia associated with helium-oxygen therapy in neonates. J Pediatr 1985 0.77
428 Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology 1999 0.77
429 Pharmacokinetic interaction between zidovudine and trimethoprim/sulphamethoxazole in HIV-1 infected children. Can J Infect Dis 2000 0.77
430 The pharmacokinetics of alfentanil in children. Anesthesiology 1987 0.77
431 The efficacy of diazepam in the treatment of acute iron overload in rats. Can J Physiol Pharmacol 1998 0.77
432 Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery. Anesth Analg 1984 0.77
433 Morphine excretion in breast milk and resultant exposure of a nursing infant. J Toxicol Clin Toxicol 1990 0.77
434 The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model. Anticancer Res 2012 0.77
435 A simple way to improve the chances for acceptance of your scientific paper. N Engl J Med 1986 0.77
436 Ethics of drug studies in infants: how many samples are required for accurate estimation of pharmacokinetic parameters in neonates? J Pediatr 1987 0.77
437 Comparison of oral and intravenous administration of sodium bromide for extracellular water measurements. Am J Clin Nutr 1987 0.77
438 Response to hepatitis B immunization in children with hemophilia: relationship to infection with human immunodeficiency virus type 1. J Pediatr 1990 0.77
439 Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta. J Obstet Gynaecol 2008 0.77
440 Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies. Pediatr Nephrol 2001 0.77
441 The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers. J Pharmacol Exp Ther 1997 0.77
442 Analgesic and respiratory effects of epidural sufentanil in patients following thoracotomy. Anesthesiology 1988 0.77
443 Interaction between digoxin and propafenone in children. J Pediatr 1990 0.77
444 Acyclovir excretion in human breast milk. Ann Pharmacother 1994 0.76
445 Continuous infusions of lumbar epidural fentanyl and intravenous fentanyl for post-thoracotomy pain relief. I: Analgesic and pharmacokinetic effects. Can J Anaesth 1990 0.76
446 The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy. Eur J Obstet Gynecol Reprod Biol 2001 0.76
447 Neurodevelopment after in utero amiodarone exposure. Neurotoxicol Teratol 1999 0.76
448 An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children. Bone Marrow Transplant 1997 0.76
449 A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids. Ther Drug Monit 1989 0.76
450 Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children. Eur J Haematol 2001 0.76
451 In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line. Biochem Biophys Res Commun 1993 0.76
452 Confirmation of cocaine use during pregnancy: a critical review. Ther Drug Monit 2001 0.76
453 Experience with misoprostol therapy for NSAID gastropathy in children. Ann Rheum Dis 1995 0.76
454 Clinical use of the Medication Event Monitoring System: a new window into pediatric compliance. Clin Pharmacol Ther 1992 0.76
455 Reversible hypertrophic osteoarthropathy associated with cyanotic congenital heart disease. Am J Dis Child 1982 0.76
456 Cocaine toxicity and isoflurane anesthesia: hemodynamic, myocardial metabolic, and regional blood flow effects in swine. J Cardiothorac Vasc Anesth 1996 0.76
457 Review of a home-based palliative care program for children with malignant and non-malignant diseases. J Palliat Care 1997 0.76
458 Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients. Ann N Y Acad Sci 1990 0.76
459 Can we use anxiolytics during pregnancy without anxiety? Can Fam Physician 2000 0.76
460 In vitro testing for hypersensitivity-mediated adverse drug reactions: challenges and future directions. Clin Pharmacol Ther 2011 0.76
461 Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995 0.76
462 Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 1999 0.76
463 Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000 0.76
464 The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy. J Obstet Gynaecol 2009 0.76
465 Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008 0.76
466 Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in vitro, is diminished by silymarin. Skin Pharmacol 1995 0.76
467 Characteristics of pregnant women exposed to cocaine in Toronto between 1985 and 1990. CMAJ 1991 0.76
468 The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure. Ther Drug Monit 2001 0.76
469 Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Can Fam Physician 2005 0.76
470 The pharmacokinetics of extended release felodipine in children. Eur J Clin Pharmacol 1996 0.75
471 Finasteride. Does it affect spermatogenesis and pregnancy? Can Fam Physician 2001 0.75
472 Can herbal products be used safely during pregnancy? Focus on echinacea. Can Fam Physician 2001 0.75
473 Dilemmas in care of the elderly. Can Fam Physician 1995 0.75
474 Morphine in kidney failure. Clin Pharmacol Ther 1994 0.75
475 Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study. J Allergy Clin Immunol 1999 0.75
476 Controlled pilot study of rapid amphotericin B infusions. Arch Dis Child 1997 0.75
477 A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension. Arch Dis Child 1995 0.75
478 Ganciclovir in newborns. Clin Pharmacol Ther 1993 0.75
479 Effect of infusion rates on toxicity of amphotericin B. Antimicrob Agents Chemother 1992 0.75
480 The effectiveness of deferiprone in thalassemia. Blood 1997 0.75
481 The three most common occupational exposures reported by pregnant women: an update. Am J Obstet Gynecol 1991 0.75
482 Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics. Med Pediatr Oncol 1996 0.75
483 Rarity of systemic lupus erythematosus after oral iron chelator L1. Lancet 1991 0.75
484 Medication errors in paediatrics: a case report and systematic review of risk factors. Paediatr Drugs 2000 0.75
485 The pharmacokinetics of inhaled N2O in children. Res Commun Chem Pathol Pharmacol 1985 0.75
486 Managing hypothyroidism during pregnancy. Can Fam Physician 2001 0.75
487 Disposition of maternal ketoconazole in breast milk. Am J Obstet Gynecol 1995 0.75
488 Children of Neverland. Can Fam Physician 1997 0.75
489 Pharmacologic treatment of nausea and vomiting during pregnancy. Can Fam Physician 1998 0.75
490 Sclerodermalike esophageal disease in children of mothers with silicone breast implants. JAMA 1994 0.75
491 Comment: possible mechanism of digoxin-itraconazole interaction. Ann Pharmacother 1997 0.75
492 Managing exposure to chickenpox during pregnancy. New program. Can Fam Physician 1998 0.75
493 Child behaviour following low to moderate maternal drinking in pregnancy. BJOG 2010 0.75
494 Getting the facts straight. CMAJ 1992 0.75
495 Risks for FAS. Teratology 1999 0.75
496 Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants. Can Fam Physician 2000 0.75
497 Congenital cytomegalovirus infection. Is there a breakthrough? Can Fam Physician 2001 0.75
498 Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy. J Obstet Gynaecol 2012 0.75
499 Maternal cocaine use and risk of sudden infant death. J Pediatr 1989 0.75
500 Update on perinatal HIV. Can Fam Physician 2001 0.75
501 The ethics of multiple blood sampling in children for research. Ther Drug Monit 1997 0.75
502 Simple measurement of captopril in plasma by high-performance liquid chromatography with ultraviolet detection. Ther Drug Monit 1990 0.75
503 Digoxin and indomethacin in preterm infants with PDA. J Pediatr 1984 0.75
504 Unexpected alterations in fentanyl pharmacokinetics in children undergoing cardiac surgery: age related or disease related? Dev Pharmacol Ther 1986 0.75
505 Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction. Am J Cardiol 1986 0.75
506 Evaluation of a new method for the prevention of neonatal anemia. Pediatr Res 1989 0.75
507 A summer-camp outbreak of beta hemolytic streptococcal tonsillitis. Can J Public Health 1985 0.75
508 [Failure of diphenylhydantoin treatment in children]. Harefuah 1980 0.75
509 Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. Crit Care Nurse 1990 0.75
510 Interactions of drugs with the developing kidney. Pediatr Clin North Am 1995 0.75
511 Predicting phenytoin serum concentrations. Neurology 1983 0.75
512 Pursuing teratogenic causes of multiple congenital contractures. J Toxicol Clin Toxicol 1988 0.75
513 Proactive approach for the evaluation of fetal safety in chemical industries. Teratology 1999 0.75
514 Once-daily versus twice-daily dosing of digoxin in the pediatric age group. J Pediatr 1990 0.75
515 Breast cancer during pregnancy. Approach to rational management. Can Fam Physician 1998 0.75
516 Optimization of gentamicin therapy in very low birth weight infants. Pediatr Pharmacol (New York) 1985 0.75
517 Tuberculosis during pregnancy. Can Fam Physician 1996 0.75
518 Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia. Clin Pharmacol Ther 1986 0.75
519 Estimation of neonatal exposure after accidental ingestion of lufenuron in a breastfeeding mother. J Hum Lact 2000 0.75
520 Is chronic poisoning with acetaminophen in children a frequent occurrence in Toronto? Can J Clin Pharmacol 2001 0.75
521 Twin-image elimination in in-line holography of finite-support complex objects. Opt Lett 1991 0.75
522 The fetal safety of cetirizine: an observational cohort study and meta-analysis. J Obstet Gynaecol 2014 0.75
523 Rationale for treating pregnant smokers with nicotine patches. Can Fam Physician 1998 0.75
524 Counseling sexually active teenagers treated with potential human teratogens. J Adolesc Health 1997 0.75
525 The quinidine-digoxin interaction. J Pharm Sci 1982 0.75
526 The transfer, of cocaethylene across the human term placental cotyledon perfused in vitro. Reprod Toxicol 1997 0.75
527 Discrepancy between CYP2D6 phenotype and genotype derived from post-mortem dextromethorphan blood level. Forensic Sci Int 2000 0.75
528 Cellular mechanisms of digoxin transport and toxic interactions in the kidney. Vet Hum Toxicol 1986 0.75
529 Handling of digoxin and ouabain by renal tubular cells (LLC-PK1). J Pharmacol Exp Ther 1992 0.75
530 Cocaine transfer across a cocaine exposed placental cotyledon perfused in vitro. Life Sci 1995 0.75
531 The feasibility of using EMLA (eutectic mixture of local anaesthetics) cream in pediatric outpatient clinics. Can J Hosp Pharm 1990 0.75
532 [Orthostatic induced ventricular tachycardia in a patient with Romano-Ward syndrome]. Harefuah 1985 0.75
533 Survey of Canadian hospital-based and private pediatricians on clinical pharmacology. J Med Educ 1986 0.75
534 Hypothermia, alkalosis, and barbiturate clearance. J Pediatr 1983 0.75
535 Clinical studies on iron chelation in patients with thalassemia major. Haematologica 1991 0.75
536 [Overdose of chloral derivatives in children]. Harefuah 1980 0.75
537 VDTs: is there a danger of radiation? CMAJ 1986 0.75
538 Biological and toxic properties of deferoxamine. Prog Clin Biol Res 1989 0.75
539 Effect of counseling on maternal reporting of adverse effects in nursing infants exposed to antibiotics through breast milk. Reprod Toxicol 1995 0.75
540 Efficacy of amlodipine in pediatric bone marrow transplant patients. Clin Pediatr (Phila) 1998 0.75
541 Pulmonary valve stenosis and hemophilia A. Report of three cases and discussion of a possible genetic linkage. Arch Intern Med 1986 0.75
542 Renal tubular cell handling of digoxin and ouabain--in vitro study using LLC-PK1 cell lines. Toxicol Lett 1990 0.75
543 The antiemetic effect of cetirizine during pregnancy. Ann Pharmacother 2000 0.75
544 Pregnancy outcome following fetal exposure to tiaprofenic acid in the first trimester. Am J Perinatol 1993 0.75
545 Nonsedating antihistamines in pregnancy. Can Fam Physician 1997 0.75
546 Fetal outcome following intrauterine amantadine exposure. Reprod Toxicol 1991 0.75
547 Clinical utilization of the neonatal hair test for cocaine: a four-year experience in Toronto. Biol Neonate 1997 0.75
548 Renal tubular interactions of digoxin. Am J Cardiol 1984 0.75
549 Cardiovascular effects of cimetidine. Ann Intern Med 1983 0.75
550 Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. Can Fam Physician 2000 0.75
551 Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys. Reprod Toxicol 1998 0.75
552 Evaluating a filter device used for intermittent intravenous drug delivery to newborn infants. Am J Hosp Pharm 1985 0.75
553 Controversies in antenatal corticosteroid treatment. Can Fam Physician 2000 0.75
554 Single dose and steady state pharmacokinetics of intravenous acyclovir in children undergoing bone marrow and liver transplant. Pediatr Infect Dis J 1995 0.75
555 Interaction of digoxin with verapamil, indomethacin, and other coadministered drugs: a comparative study in rat tissue. Prog Clin Biol Res 1983 0.75
556 Drinking and pregnancy. CMAJ 1991 0.75
557 Antenatal sonography of fetal malformations associated with drugs and chemicals: a guide. Am J Obstet Gynecol 1987 0.75
558 Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients. Bone Marrow Transplant 1993 0.75
559 Calcium blocking agents in pediatric emergency care. Pediatr Emerg Care 1990 0.75
560 Prostaglandin-induced antral hyperplasia in neonates: clinical experience and dose-response characteristics. Dev Pharmacol Ther 1993 0.75
561 Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children. Ther Drug Monit 1984 0.75
562 Flux-flow resistivity anisotropy in the instability regime of the a-b plane of epitaxial superconducting YBa2Cu3O7-delta thin films. Phys Rev Lett 2006 0.75
563 [Cold injuries. Part III: superficial cold lesions]. Harefuah 1976 0.75
564 Dextromethorphan. Extrapolation of findings from reproductive studies in animals to humans. Can Fam Physician 1999 0.75
565 Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with homozygous beta-thalassemia. Clin Pharmacol Ther 1994 0.75
566 Use of a eutectic mixture of local anesthetics for prolonged subcutaneous drug administration. J Clin Pharmacol 1995 0.75
567 The chest radiograph in the diagnosis of atypical nephritis due to infectious mononucleosis. J Can Assoc Radiol 1984 0.75
568 [Measurement of drugs in neonatal hair--a window to fetal exposure]. Harefuah 1995 0.75
569 A high-performance liquid chromatographic method for the measurement of the iron chelator 1,2-dimethyl-3-hydroxypyridin-4-one in human plasma. Ther Drug Monit 1991 0.75
570 Pharmacokinetics of deferoxamine with and without iron load. Vet Hum Toxicol 1989 0.75
571 Evaluation of therapeutic drug monitoring of methotrexate in saliva of children with rheumatic diseases. Ther Drug Monit 1995 0.75
572 Intravenous administration of alpha-galactosyl carbohydrates reduces in vivo baboon serum cytotoxicity to pig kidney cells and transplanted pig hearts. Transplant Proc 1994 0.75
573 Home-based palliative care for children--Part 1: The institution of a program. J Palliat Care 1990 0.75
574 Bias in maternal reports of smoking during pregnancy associated with fetal distress. Can J Public Health 2001 0.75
575 Adverse placental effect of formic acid on hCG secretion is mitigated by folic acid. Alcohol Alcohol 2013 0.75
576 Clinical toxicology of the neonate. Semin Perinatol 1992 0.75
577 Dermatologic drugs in pregnancy. Clin Dermatol 1992 0.75
578 Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. Med Pediatr Oncol 2000 0.75
579 Alert over sound-alike drugs. CMAJ 1997 0.75
580 Counseling psychiatric patients about drug exposures during pregnancy. Can Fam Physician 1998 0.75
581 [Accidental hypothermia in healthy adults]. Harefuah 1976 0.75
582 Pharmacokinetic studies of nifedipine and digoxin co-administration. Int J Clin Pharmacol Ther Toxicol 1986 0.75
583 A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee. Reprod Toxicol 2001 0.75
584 Interaction between digoxin and commonly coadministered drugs in children. Pediatrics 1985 0.75
585 Occupational exposure to mercury. What is a safe level? Can Fam Physician 1999 0.75
586 The use of topical 5% imiquimod during pregnancy: a case series. Reprod Toxicol 2005 0.75
587 Semiquantitative determination of liver specific antigen in the urine or rats with toxic hepatic necrosis. Acta Hepatogastroenterol (Stuttg) 1979 0.75
588 Diurnal variation of methotrexate disposition in children with acute leukaemia. Eur J Clin Pharmacol 1991 0.75
589 Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. Dev Pharmacol Ther 1991 0.75
590 Functional asplenia in immunoblastic lymphoma. Arch Intern Med 1982 0.75
591 Prediction of atrial and ventricular fibrillation complicating myocardial infarction from admission data: a prospective study. Clin Cardiol 1987 0.75
592 Formation of the Organization of Teratology Information Services (OTIS). The OTIS Executive Committee. Reprod Toxicol 1991 0.75
593 Digoxin-verapamil interaction: in vitro studies in rat tissue. J Cardiovasc Pharmacol 1983 0.75
594 Digoxin-verapamil interaction--is it mutual? Circulation 1983 0.75
595 [Medical management of seizures during infancy and childhood]. Harefuah 1989 0.75
596 Is topical tretinoin safe during the first trimester? Can Fam Physician 1998 0.75
597 Taking folic acid during pregnancy. Don't leave it too late. Can Fam Physician 1997 0.75
598 Longitudinal change in the treatment of nausea and vomiting of pregnancy in Ontario. Can J Clin Pharmacol 2000 0.75
599 Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney. Res Commun Chem Pathol Pharmacol 1984 0.75
600 Theophylline pharmacokinetics in adolescent females following coadministration of oral contraceptives. Clin Invest Med 1985 0.75
601 The use of teratogen information services for research: assessment of reliability of data entry. Reprod Toxicol 1995 0.75
602 Misinterpretation of iron-binding capacity in the presence of deferoxamine. J Pediatr 1991 0.75
603 Observation of the nonlinear meissner effect in YBCO thin films: evidence for a D-wave order parameter in the bulk of the cuprate superconductors. Phys Rev Lett 2004 0.75
604 Pharmacokinetics of arginine butyrate in patients with hemoglobinopathy. Environ Toxicol Pharmacol 1996 0.75
605 [Intravenous streptokinase in acute myocardial infarction]. Harefuah 1985 0.75
606 Aspirin therapy in Kawasaki syndrome. J Pediatr 1985 0.75
607 Interpretation of excessive serum concentrations of digoxin in children. Am J Cardiol 1985 0.75
608 Early treatment of acute myocardial infarction with intravenous streptokinase. A high-risk syndrome. Arch Intern Med 1987 0.75
609 Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada. Vet Hum Toxicol 1989 0.75
610 [Importance of early administration of intravenous streptokinase in acute myocardial infarction]. Harefuah 1986 0.75
611 Comment: monitoring pediatric iv drugs. Drug Intell Clin Pharm 1985 0.75
612 Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994 0.75
613 Periconceptional use of folic acid to reduce the rates of neural tube defects: is it working? Reprod Toxicol 2000 0.75
614 Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability. Isr J Med Sci 1982 0.75
615 [Cold injuries, Part II: Accidental hypothermia]. Harefuah 1976 0.75
616 Reproducibility of medical information obtained via the telephone vs personal interview. Vet Hum Toxicol 1999 0.75
617 Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma 1993 0.75
618 The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics. J Clin Pharmacol 1992 0.75
619 Coexistence of Kaposi's sarcoma and chronic lymphocytic leukemia in the same lymph node. Acta Haematol 1985 0.75
620 [Red man syndrome after vancomycin]. Harefuah 1992 0.75
621 Erythema infectiosum (Fifth disease) and pregnancy. Can Fam Physician 1999 0.75
622 Effects of age and cardiac shunts on the measured uptake of nitrous oxide in children. Res Commun Chem Pathol Pharmacol 1991 0.75
623 Kinetics of intravenous phenytoin in children. Pediatr Pharmacol (New York) 1984 0.75
624 Theophylline and diet. Pediatrics 1981 0.75
625 Pharmacokinetics of fentanyl in children with renal disease. Res Commun Chem Pathol Pharmacol 1984 0.75
626 Maternal spermicide use and adverse reproductive outcome: a meta-analysis. Am J Obstet Gynecol 1990 0.75
627 Prenatal adverse effects of various drugs and chemicals. A review of substances of frequent concern to mothers in the community. Med Toxicol Adverse Drug Exp 1988 0.75
628 Fentanyl-oxygen versus fentanyl-N2O/oxygen anaesthesia in children undergoing cardiac surgery. Can Anaesth Soc J 1986 0.75
629 Obstetric and neonatal effects of drugs of abuse. Emerg Med Clin North Am 1990 0.75
630 Evaluation of brompheniramine safety in pregnancy. Reprod Toxicol 1993 0.75
631 Efficacy of deferiprone in the treatment of acute iron intoxication in rats. J Toxicol Clin Toxicol 1996 0.75
632 Evidence-based pain management for infants. Curr Opin Pediatr 1998 0.75
633 Comparison of methods for prediction of nephrotoxicity during development. Dev Pharmacol Ther 1992 0.75
634 Hypothetical framework for a relationship between maternal thyroid function, nausea and vomiting of pregnancy, and congenital heart disease. Med Hypotheses 2001 0.75
635 Amphotericin-induced heart-rate decrease in children. Clin Pediatr (Phila) 1995 0.75
636 Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial. J Obstet Gynaecol 2013 0.75
637 Changing trends in the treatment of asthma in a tertiary Canadian pediatric hospital. J Asthma 1993 0.75
638 Biotransformation of carcinogenic arylamines and arylamides by human placenta. J Lab Clin Med 1994 0.75
639 Gentamicin-digoxin interaction in the rat kidney. Isr J Med Sci 1985 0.75
640 Methodological issues in studying the effect of the new oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) on absorption of iron. Vet Hum Toxicol 1990 0.75
641 Screening of the epileptic patient--is it worth the trouble? Can J Neurol Sci 1989 0.75
642 Constrictive pericarditis following coronary-artery bypass grafting in a patient with chronic asymptomatic pericardial disease. Cardiology 1983 0.75
643 Estimation of fetal risk from aerosolized pentamidine in pregnant healthcare workers. Chest 1994 0.75